MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.

Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, Parviz Vahedi, Afshin Derakhshani, Oronzo Brunetti, Amir Baghbanzadeh, Behzad Mansoori, Nicola Silvestris, Behzad Baradaran

Research output: Contribution to journalReview articlepeer-review


MicroRNAs (miRNAs) are small and non-coding RNAs that display aberrant expression in the tissue and plasma of cancer patients when tested in comparison to healthy individuals. In past decades, research data proposed that miRNAs could be diagnostic and prognostic biomarkers in cancer patients. It has been confirmed that miRNAs can act either as oncogenes by silencing tumor inhibitors or as tumor suppressors by targeting oncoproteins. MiR-144s are located in the chromosomal region 17q11.2, which is subject to significant damage in many types of cancers. In this review, we assess the involvement of miR-144s in several cancer types by illustrating the possible target genes that are related to each cancer, and we also briefly describe the clinical applications of miR-144s as a diagnostic and prognostic tool in cancers.

Original languageEnglish
Article number2578
JournalInternational Journal of Molecular Sciences
Issue number7
Publication statusPublished - Apr 8 2020


  • Animals
  • Biomarkers, Tumor/analysis
  • Gene Expression Regulation, Neoplastic
  • Genes, Neoplasm
  • Humans
  • MicroRNAs/analysis
  • Neoplasms/diagnosis
  • Prognosis


Dive into the research topics of 'MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.'. Together they form a unique fingerprint.

Cite this